Guangzhou Decheng Biotechnology Co., LTD – Trademark Portfolio
Entity Type: 99
Guangzhou Decheng Biotechnology Co., LTD holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include D-PEN, O-PEN, S-PEN, DOCHEK, and MISSLAN. The owner is based in Science City,Guangzhou.
Science City,Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Decheng Biotechnology Co., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Guangzhou Decheng Biotechnology Co., LTD have?
Guangzhou Decheng Biotechnology Co., LTD has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned.
What trademark classes does Guangzhou Decheng Biotechnology Co., LTD file in?
Guangzhou Decheng Biotechnology Co., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Guangzhou Decheng Biotechnology Co., LTD's most well-known trademarks?
Guangzhou Decheng Biotechnology Co., LTD's registered trademark portfolio includes well-known marks such as D-PEN, O-PEN, S-PEN, DOCHEK, and MISSLAN. These are among 7 currently registered trademarks in the portfolio.
What is Guangzhou Decheng Biotechnology Co., LTD's trademark registration success rate?
Guangzhou Decheng Biotechnology Co., LTD has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.